Cargando…
Rifampicin attenuates experimental autoimmune encephalomyelitis by inhibiting pathogenic Th17 cells responses
Rifampicin, a broad‐spectrum antibiotic, has neuroprotective, immunosuppressive, and anti‐inflammatory properties. However, the effect of rifampicin on autoimmune disorders of the nervous system is not clear. In this study, we investigated whether rifampicin was beneficial to myelin oligodendrocyte...
Autores principales: | Ma, Ke, Chen, Xi, Chen, Jia‐Cheng, Wang, Ying, Zhang, Xi‐meng, Huang, Fan, Zheng, Jun‐Jiong, Chen, Xiong, Yu, Wei, Cheng, Ke‐Ling, Feng, Yan‐Qing, Gu, Huai‐yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6680363/ https://www.ncbi.nlm.nih.gov/pubmed/27774592 http://dx.doi.org/10.1111/jnc.13871 |
Ejemplares similares
-
Functional and Pathogenic Differences of Th1 and Th17 Cells in Experimental Autoimmune Encephalomyelitis
por: Domingues, Helena S., et al.
Publicado: (2010) -
SKI Expression Suppresses Pathogenic Th17 Cell Response and Mitigates Experimental Autoimmune Encephalomyelitis
por: Li, Ping, et al.
Publicado: (2021) -
BAFF Promotes Th17 Cells and Aggravates Experimental Autoimmune Encephalomyelitis
por: Zhou, Xiaohui, et al.
Publicado: (2011) -
Kirenol Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Differentiation of Th1 and Th17 Cells and Inducing Apoptosis of Effector T Cells
por: Xiao, Juan, et al.
Publicado: (2015) -
4-Ethylguaiacol modulates neuroinflammation and Th1/Th17 differentiation to ameliorate disease severity in experimental autoimmune encephalomyelitis
por: Weng, Wen-Tsan, et al.
Publicado: (2021)